- Home
- NTIC vs TLSA Comparison
NTIC vs TLSA Comparison
Compare NTIC & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTIC
- TLSA
- Stock Information
- Founded
- NTIC 1970
- TLSA 2013
- Country
- NTIC United States
- TLSA United Kingdom
- Employees
- NTIC N/A
- TLSA N/A
- Industry
- NTIC Industrial Specialties
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- NTIC Industrials
- TLSA Health Care
- Exchange
- NTIC Nasdaq
- TLSA Nasdaq
- Market Cap
- NTIC 105.9M
- TLSA 87.8M
- IPO Year
- NTIC N/A
- TLSA 2000
- Fundamental
- Price
- NTIC $7.30
- TLSA $1.51
- Analyst Decision
- NTIC Buy
- TLSA
- Analyst Count
- NTIC 1
- TLSA 0
- Target Price
- NTIC $20.00
- TLSA N/A
- AVG Volume (30 Days)
- NTIC 45.0K
- TLSA 407.1K
- Earning Date
- NTIC 04-10-2025
- TLSA 05-13-2025
- Dividend Yield
- NTIC 2.99%
- TLSA N/A
- EPS Growth
- NTIC N/A
- TLSA N/A
- EPS
- NTIC 0.38
- TLSA N/A
- Revenue
- NTIC $84,445,763.00
- TLSA N/A
- Revenue This Year
- NTIC $2.05
- TLSA N/A
- Revenue Next Year
- NTIC $4.70
- TLSA N/A
- P/E Ratio
- NTIC $19.26
- TLSA N/A
- Revenue Growth
- NTIC 2.11
- TLSA N/A
- 52 Week Low
- NTIC $6.75
- TLSA $0.54
- 52 Week High
- NTIC $19.63
- TLSA $1.91
- Technical
- Relative Strength Index (RSI)
- NTIC 31.81
- TLSA 62.62
- Support Level
- NTIC $7.33
- TLSA $1.22
- Resistance Level
- NTIC $7.62
- TLSA $1.78
- Average True Range (ATR)
- NTIC 0.21
- TLSA 0.17
- MACD
- NTIC 0.13
- TLSA 0.04
- Stochastic Oscillator
- NTIC 63.22
- TLSA 64.94
About NTIC Northern Technologies International Corporation
Northern Technologies International Corp, or NTIC is a United States-based firm that develops and markets environmentally beneficial products and services world-wide either directly or through a network of joint ventures, distributors, and agents. It operates through two segments which include ZERUST products and services and Nature-Tec products. Its main business is providing corrosion prevention solutions that are marketed under the ZERUST brand. The company also sells a portfolio of bio-based and biodegradable (compostable) polymer resin compounds and finished products marketed under the Nature-Tec brand. The ZERUST brand generates a vast majority of the revenue for the company.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.